Compare BioNano Genomics Inc (BNGO) vs Citigroup Inc. (C) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Citigroup Inc. — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Citigroup Inc. trades at $135.93 (market cap $227.75B). The key difference: Citigroup Inc. is far larger — about 16672.8× BioNano Genomics Inc's market cap, and Citigroup Inc. pays a 1.97% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | C | |
|---|---|---|
Market Cap | $13.66M | $227.75B |
Sector | Health | Financials |
52-Week High | $4.92 | $145.67 |
52-Week Low | $1.06 | $92.59 |
Enterprise Value | $16.26M | — |
Dividend Yield | — | 1.97% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Citigroup Inc.
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →
